Home/SEC 13D/G/GRCESEC 13D/GGRCE - Grace Therapeutics, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks Simplified$GRCE$2.20βΌ -39.73% YTDHealthcareAug 14, 2026 Β· ThinkSabio BlogSEC Filing Update: #GRCE Grace Therapeutics, Inc. : $2.20 Sector: Healthcare | YTD: π½ -39.73% The SEC disclosed Today (14-AUG-2026) that NANTAHALA CAPITAL MANAGEMENT, L has INCREASED #GRCE Shares by 61.80% π’ * Previous Holdings: 728.20K Shares * Current Holdings: 1.18M Shares * Increase+450.00K * Increased(%)+61.80% * Ownership: 6.75% * Estimated Investment Value: $958.50K https://www.thinksabio.com/reports/isr/GRCE π Institutional activity in the last 30 days for #GRCE: β’ OPALEYE MANAGEMENT INC β Newly bought 2,748,392 shares (07-AUG-2026) Share this postπCopy LinkMore filings for $GRCEGRCE - Grace Therapeutics, Inc. - SEC Filing Update (07-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 7, 2026π¬ Comments Loading commentsβ¦Leave a commentPost Commentβ All PostsMore SEC 13D/G